Search results - 429 results
Molecular mechanisms for the persistent bronchodilatory effect of the beta 2-adrenoceptor agonist salmeterol.
IMPLICATIONS: The ‘rebinding’ and ‘exosite’ binding mechanisms take place at a sub-cellular/molecular scale. Pending their demonstration by experiments on appropriate, simple models such as intact cells or ...
Future use of Micro-arrays in enforcement
PURPOSES", NA, Issue BfR, NA (2008) Keywords: Biology dissemination future meeting method methods ON traceability use Workshop Health Topics: Health and disease monitoring Surveillance de la santé et des ...
The anti-cancer drug 5-fluorouracil is highly active against Mycobacterium tuberculosis in vitro but not in vivo
Publication Type: Scientific poster, presentation or proceeding Authors: Vanessa Mathys; Singhal,A.; Kiass,M.; P. Lefevre; Kurepina,N.; Wang,X.M.; Mathema,B.; Baulard,A.; Bifani,P. Source: ...
Mutations associated with para-aminosalicylic acid (PAS) resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis
Publication Type: Scientific poster, presentation or proceeding Authors: Vanessa Mathys; Quatannens,J.; Wintjens,R.; Kurepina,N.; Singhal,A.; Kiass,M.; Mathema,B.; Baulard,A.; B.N. Kreiswirth; ...
Molecular characterization of genes associated with ethionamide resistance in Mycobacterium tuberculosis clinical isolates and spontaneous mutants
Publication Type: Scientific poster, presentation or proceeding Authors: Vanessa Mathys; Baulard,A.; Kurepina,N.; M. Fauville; B.N. Kreiswirth; Bifani,P. Source: 106th General Meeting, NA, Issue ...
DNA vaccines against tuberculosis.
Publication Type: Peer reviewed scientific article Authors: Ulmer, J B; Montgomery, D L; Tang, A; Zhu, L; Deck, R R; C DeWitt; Olivier J Denis; I Orme; Content, J; Huygen, K Source: Novartis Found ...
European risk assessor perspective on the quality of in vivo bioassays
Modified Organisms (ISBGMO) 2014, Issue ISBR (International Society for Biosafety Research), Cape Town, South Africa (2014) Abstract: As described in Regulation (EC) No. 1829/2003 on genetically modified ...
The burden of cystic fibrosis in Belgium: a registry-based study
using a prevalence approach (hybrid model) in a multi-aspect disease model. Results: In 2014, patients with cystic fibrosis in Belgium are accountable for 484.8 YLL s and 437.6 YLD s, corresponding with ...
Quantifying the changes in activity level of neuromuscular patients using the ACTIVLIM questionnaire: A 5-years study
den Bergh; S. Paquay; L. Servais; A. Maertens de Noordhout; J. Haan; L. De Meirleir; G. Remiche; N. Deconinck; C. Arnould; BNMDR study group Source: 12th ISPRM World Congress (2018) Keywords: Activity ...
Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively.
Publication Type: Peer reviewed scientific article Authors: C Adlhoch; R Snacken; A Melidou; S Ionescu; P Penttinen; et al. Source: (0) Health Topics: Health and disease monitoring Surveillance de ...